Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „either“
Suchtreffer
Begriffe & Kennungen
Clopidogrel Teva (hydrogen sulphate) · 4.5 · Proton Pump Inhibitors (PPI): Omeprazole 80 mg once daily administered either at the same time as clopidogrel
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.8 · Adverse reactions that occurred either during clinical studies or that were spontaneously reported are present
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.8 · In CAPRIE, in patients treated with either clopidogrel or ASA, the overall incidence of any bleeding was 9.3%.
Eintrag öffnenClopidogrel Viatris (previously Clopidogrel Taw Pharma) · 4.5 · Proton Pump Inhibitors (PPI): Omeprazole 80 mg once daily administered either at the same time as clopidogrel
Eintrag öffnenClopidogrel Viatris (previously Clopidogrel Taw Pharma) · 4.8 · In CAPRIE, in patients treated with either clopidogrel or ASA, the overall incidence of any bleeding was 9.3%.
Eintrag öffnenClopidogrel Viatris (previously Clopidogrel Taw Pharma) · 4.8 · Tabulated list of adverse reactions Adverse reactions that occurred either during clinical studies or that wer
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.5 · Proton Pump Inhibitors (PPI) Omeprazole 80 mg once daily administered either at the same time as clopidogrel o
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.8 · In CAPRIE, in patients treated with either clopidogrel or ASA, the overall incidence of any bleeding was 9.3%.
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.8 · Tabulated list of adverse reactions Adverse reactions that occurred either during clinical studies or that wer
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.5 · Proton Pump Inhibitors (PPI) Omeprazole 80 mg once daily administered either at the same time as clopidogrel o
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.8 · In CAPRIE, in patients treated with either clopidogrel or ASA, the overall incidence of any bleeding was 9.3%.
Eintrag öffnenCompetact · 4.5 · Interaction studies have shown that pioglitazone has no relevant effect on either the pharmacokinetics or phar
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.3 · Applicable to darunavir boosted with either ritonavir or cobicistat: - The combination product lopinavir/riton
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.3 · Darunavir boosted with either ritonavir or cobicistat inhibits the elimination of active substances that are h
Eintrag öffnenDarzalex · 4.8 · The most frequent adverse reactions of any grade (≥ 20% patients) with daratumumab (either intravenous or subc
Eintrag öffnenDescovy · 4.5 · Lopinavir: AUC: ↔ Cmax: ↔ Cmin: ↔ Tipranavir/ritonavir Interaction not studied with either of Co-administratio
Eintrag öffnenDescovy · 4.5 · Lopinavir: AUC: ↔ Cmax: ↔ Cmin: ↔ Tipranavir/ritonavir Interaction not studied with either of Co-administratio
Eintrag öffnenDupixent · 4.5 · 9 dupilumab-treated and placebo-treated patients. No adverse interactions between either of the non-live vacci
Eintrag öffnenDynastat · 4.5 · 7 Coadministration of valdecoxib with glibenclamide (CYP3A4 substrate) did not affect either the pharmacokinet
Eintrag öffnenDynastat · 4.5 · Coadministration of valdecoxib with glibenclamide (CYP3A4 substrate) did not affect either the pharmacokinetic
Eintrag öffnen